New pain block could cut opioid use in super obese surgery patients

NCT ID NCT06377605

Completed Symptom relief Sponsor: Amany Ahmed Eissa Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed trial tested whether a nerve block called erector spinae plane block (ESPB) can reduce pain and opioid use in super obese patients (BMI over 50) after laparoscopic bariatric surgery. Sixty participants received either the ESPB or standard local anesthetic at the incision sites. The goal was to see if ESPB provides better pain control and lowers the need for opioids, which carry risks like breathing problems in this population.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: erector spinae plane block (ESPB) with local anesthetic
What this could lead to: If effective, this nerve block could provide a safer pain management option for super obese patients after bariatric surgery, reducing reliance on opioids.
What could go wrong: This is a small, completed trial without a phase designation, so results may not apply broadly. The block may be harder to perform in super obese patients, and its effectiveness is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BARIATRIC SURGERY ERECTOR SPINAE PLANE BLOCK SUPER OBESE PATIENTS

Contacts and locations

Locations

Kasr Al Ainy Hospitals

Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.